Włodzimierz Mendrek

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy

Francis J. Giles, Elisabetta Abruzzese, Gianantonio Rosti et al. · Leukemia · 2010 · 116 citations

Medicine, Oncology, Pharmacology +5

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

Samer K. Khaled, Kathleen Claes, Yeow Tee Goh et al. · Journal of Clinical Oncology · 2022 · 98 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +14

Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study

Iwona Mitrus, Andrzej Smagur, Wojciech Fidyk et al. · Bone Marrow Transplantation · 2017 · 49 citations

Medicine, Hematology, Cell Therapy +9

Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial

Tomasz Czerw, Maria Saduś‐Wojciechowska, Katarzyna Michalak et al. · Biology of Blood and Marrow Transplantation · 2018 · 25 citations

Medicine, Hematology, Oncology +17

Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group

Sebastian Giebel, Maria Saduś‐Wojciechowska, Kazimierz Hałaburda et al. · Annals of Hematology · 2015 · 15 citations

Medicine, Oncology, Pharmacology +12